Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response. (2022)

First Author: Doykov I
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.crmeth.2022.100279

PubMed Identifier: 35975199

Publication URI: http://europepmc.org/abstract/MED/35975199

Type: Journal Article/Review

Volume: 2

Parent Publication: Cell reports methods

Issue: 9

ISSN: 2667-2375